Curve Therapeutics
Southampton
About Curve Therapeutics
Curve has developed an innovative screening platform that is transforming the discovery of first-in-class therapeutics. The platform allows functional screening of diverse, genetically encoded Microcycle™ libraries against a broad range of disease-associated targets that are present in their native conformation inside a mammalian cell. Curve is deploying this platform to build a pipeline of novel cancer drugs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $51.4M
- Funding stage: Early Stage Venture
- Last round: Series A (Feb 2024)
- Website: curvetx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Chemical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/curve-therapeutics-108117 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.